Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001654954-22-008238
Filing Date
2022-06-10
Accepted
2022-06-10 21:28:38
Documents
2
Period of Report
2022-06-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 4  
1 PRIMARY DOCUMENT section16.xml 4 7746
2 POWER OF ATTORNEY tenxpoa-gproehl.htm EX-24 6887
  Complete submission text file 0001654954-22-008238.txt   16483
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Issuer) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 10590 W OCEAN AIR DR STE 200 SAN DIEGO CA 92130 8583145700
PROEHL GERALD T (Reporting) CIK: 0001279191 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-34600 | Film No.: 221010557
SIC: 2834 Pharmaceutical Preparations